Background. Endemic measles transmission was declared eliminated in the United States in 2000. To ensure that elimination can be maintained, high population immunity must be sustained and monitored. Testing for measles antibody was included in the National Health and Nutrition Examination Survey (NHANES), a nationally representative survey, conducted during 1999 -2004.
Measles is a highly infectious disease that can cause rash, fever, diarrhea, pneumonia, encephalitis, and death. Although measles is endemic in most of the world, in March 2000 the ongoing transmission of measles virus was declared to be eliminated in the United States, an achievement attributed to the success of the vaccination program [1] . Measles vaccine was introduced in the United States during 1963. The vaccination program consisted of routine vaccination of infants and immunization of all susceptible children either when they entered school or at other places of congregation; however, school immunization laws started in all states during 1981. Although school immunization requirements were extremely effective in reducing measles in schoolchildren, a single dose of measles vaccine was not sufficient to prevent transmission in all settings. Therefore, a second dose of measles-containing vaccine (MCV) for school-age children was recommended during 1989 [2] . The increase of vaccination coverage of children 19 -35 months of age-to 90% since 1996 [2] -and the increased second-dose coverage of children in all grades, as recommended by the Advisory Committee on Immunization Practices during 1998 [3] , led to a dramatic decrease in the incidence of measles, which has been Ͻ1 case/million since 1997 [4 -6] . Since 1997, most cases have been associated with importations of the disease [4 -6] . The importation of measles into the United States is a reminder that population immunity must be monitored to ensure that levels of measles antibody remain high enough to maintain the elimination of endemic measles transmission in the United States.
Estimates of the national seroprevalence of measles IgG antibody were first determined by the National Health and Nutrition Examination Survey (NHANES) III, conducted during 1988 -1994 [7] . At that time, the seroprevalence of measles antibody was 93%, with significant differences by race/ethnicity and birth cohort. Mathematical models have estimated that the herd immunity threshold necessary to interrupt measles transmission in the United States is 93%-95% [8] . Data from NHANES III demonstrated that many population subgroups had prevalence estimates below this level and could therefore sustain a measles outbreak if the virus was reintroduced. To continue to monitor measles serostatus in the US population, testing for measles antibody was included in NHANES 1999 -2004. The present study considers the seroprevalence of measles antibody in participants who were 6 -49 years of age during these survey years, to assess national immunization efforts and to reassess whether any deficiencies in the levels of measles antibody still exist in parts of the US population.
METHODS
Survey design and participants. The NHANES is conducted by the National Center for Health Statistics, Centers for Disease Control and Prevention (CDC), to provide national statistics on the health and nutritional status of the noninstitutionalized civilian population through household interviews, standardized physical examinations, and the collection of biologic samples in special mobile examination centers [9] . In 1999, NHANES became a continuous survey, with data release every 2 years. The sampling plan for the survey was a stratified, multistage, probability-cluster design, to provide a sample that is representative of the US population [9] . Black Americans, Mexican Americans, adolescents, and low-income persons were sampled at higher frequencies than were other participants, to provide stable estimates for these groups.
Serum samples from participants 6 -49 years of age were available for testing for the presence of measles antibody. Race/ ethnic group was categorized on the basis of a subject's selfidentification as non-Hispanic white, non-Hispanic black, or Mexican American. Subjects who did not fit into one of these categories were classified as "other" and were analyzed with the total population but not in terms of a separate racial/ethnic subgroup. Other variables analyzed with the NHANES 1999 -2004 test results include (1) family income based on a poverty-index ratio, calculated by dividing total family income by the povertythreshold index adjusted for family size at year of the interview and categorized as either below the poverty level (Ͻ1) or at or above the poverty level (1) [10] ; (2) birthplace, categorized as within or outside the United States; (3) health insurance, categorized as any or none; and (4) regular health-care provider, defined as at least 1 regular source of health care. For those 20 -49 years of age, education was measured as last year of school completed and was categorized into 3 levels (less than high school graduate, high school graduate, and more than a high school education); marital status was grouped as ever or never married.
Informed consent was obtained from all participants, and the Ethical Review Board of the National Center for Health Statistics of the CDC approved the protocol.
Laboratory testing. Levels of measles IgG antibody were measured by an in-house enzyme immunoassay that used a lysate of measles virus-infected human fetal diploid lung cells (HFDL) as the viral antigen and a lysate of uninfected HFDL from the same passage as the control antigen (California State Department of Public Health) [11] . All sera were tested at a single dilution of 1:200. Measles serostatus was determined by using an index that was calculated by subtracting the absorbance of control-antigen wells from the mean optical-density value of the duplicate viral-antigen wells and dividing the result by the predetermined cutoff value, which was defined as the mean ϩ 3 SD absorbance obtained for a large number of sera that tested negative for measles by immunofluorescent-antibody and plaque reduction-neutralization assays. An index value 1.0 was considered to be an indication of the presence of measles antibody.
Statistical analysis. To assess the seroprevalence of measles antibody in the study population overall, participants were grouped into cohorts based on birth years, to capture difference over time, in measles-antibody response to change in vaccination policies. To ensure that there was a sufficient sample size for each group, participants were grouped into the following birth cohorts: (1) 1949 -1966, the era before the federal initiative for measles elimination; (2) 1967-1976, the early implementation of the vaccination program; (3) 1977-1986, the more fully implemented vaccine era; and (4) 1987-1998, the most recent era. Estimates of seroprevalence were weighted to represent the total civilian noninstitutionalized US household population and to account for oversampling and nonresponse to the household interview and physical examination [12] . SEs were calculated by SUDAAN, a family of statistical procedures for analysis of data from complex sample surveys [13] . Estimates were considered to be unstable if the relative SE around the proportion of participants who were not seropositive for measles IgG antibody was Ͼ30%; 95% confidence intervals [CIs] were calculated by an exact binominal method for calculation of CIs [14] . Differences between seroprevalences were evaluated by examination of P values calculated by a univariate t statistic obtained from a general linear contrast procedure in SUDAAN; P Ͻ .05 was considered to be significant.
To identify independent predictors of measles seropositivity in the birth cohort that had the lowest seroprevalence of measles antibody (i.e., birth cohort 1967-1976)-and that therefore was at greater risk for infection-a backward stepwise logistic modeling procedure in SUDAAN was used, where a P Ͻ .05 from the Satterthwaite adjusted F statistic was considered to be significant. There were no significant interactions between birth cohort and the included demographic variables. Odds ratios and their 95% CIs are reported for all significant cofactors that remained in the final model.
RESULTS
Response rates. Of the 18,433 participants 6 -49 years of age who were interviewed for NHANES 1999 -2004, 17,672 (96%) were examined by a physician, and 16,049 (11% of those examined) had their sera tested for the presence of measles antibody. Of those examined, the percentage of participants tested for the presence of measles antibody was lower (1) (2) in US-born participants than in foreign-born participants (90% vs. 92%). The percentage of those tested was lowest in the youngest age group (6 -11 years of age [83%]), with no other consistent trends with age being observed (range in the other age groups, 91%-95%). The percentage of participants whose sera was tested did not vary by sex or poverty index.
Seroprevalence of measles antibody. During 1999 -2004, in the US population 6 -49 years of age, the overall seroprevalence of measles IgG antibody was 95.9% (95% CI, 95.1%-96.5%) (table 1). Figure 1 depicts the seroprevalence by birth cohort, with the youngest and oldest birth cohorts expanded into 2 additional groups (1949 -1956 [n ϭ 1069] and 1997-1998 [n ϭ 119]) to reflect changes in epidemiology and vaccination program-implementation efforts over time. The seroprevalence by birth cohort was similar for non-Hispanic whites and Mexican Americans and was lowest in participants born during 1967-1976. In non-Hispanic blacks, the seroprevalence by birth cohort was less variable.
Predictors of the presence of measles antibody. The seroprevalence of measles antibody in non-Hispanic blacks (98.6% [95% CI, 98.0%-99.1%]) was significantly higher than that in non-Hispanic whites (95.5% [95% CI, 94.5%-96.3%]), in all birth cohorts combined (P Ͻ .001) and in each of the individual birth cohorts (P Ͻ .05) (table 1). The seroprevalence of measles antibody in Mexican Americans (94.1% [95% CI, 93.1%-95.1%]) was lower than that in non-Hispanic whites, in all birth cohorts combined (P Ͻ .05) and in the 1977-1986 birth cohort (P Ͻ .01). Also, non-Hispanic blacks had a significantly higher seroprevalence than did Mexican Americans, in all birth cohorts combined (P Ͻ .001) and in those born after 1966 (comparisons not presented in table 1).
In 05) . Service in the military was also significantly associated with increased measles seropositivity, both in the study population overall (P Ͻ .05) and in the 1967-1976 birth cohort (P Ͻ .01).
A logistic regression analysis was performed to consider independent predictors of the seroprevalence of measles antibody in participants in the 1967-1976 birth cohort, because this group had the lowest seroprevalence. After adjustment for all other significant cofactors, non-Hispanic black race/ethnicity was still the strongest predictor of the presence of measles antibody (odds ratio, 5.9 [95% CI, 2.7-12.8]), followed by foreign birth (table  2) . Educational and health-insurance status also remained as positive predictors in the model.
DISCUSSION
In the present study's representative sample of the US population 6 -49 years of age, the overall seroprevalence of measles IgG antibody was 95.9% during 1999 -2004. When the sample was examined in terms of race/ethnicity and birth cohort, measles seropositivity was at or above the estimated threshold of 93%-95% that is needed for elimination of measles, in all birth cohorts except that of 1967-1976 [8] . The lower seroprevalence in this latter birth cohort is consistent with previous findings by NHANES III [7] and other previous and smaller studies [15] [16] [17] , and the most likely reasons for it are (1) the lower vaccination coverage of children before the widespread implementation of school immunization requirements and (2) a decrease in vaccine availability during 1969 -1971, a period when federal funding for vaccine purchase was suspended [18] . Although any population that has measles-seronegative individuals regardless of history of immunization can experience an outbreak [19] and lower immunity levels may be sufficient in less dense populations [20] , this birth cohort represents a population with an increased number of measles-seronegative individuals who might be at in- creased risk for disease. Higher education, which is an indicator of socioeconomic status, and health insurance were predictors of seropositivity for measles antibody in this birth cohort, even after adjustment for race/ethnicity, and other studies [21, 22] have found these variables to be associated with higher vaccination coverage.
In all birth cohorts, the seroprevalence of measles antibody was significantly higher in non-Hispanic blacks than that in non-Hispanic whites and Mexican Americans, difference that remained regardless of the vaccination era and that probably represents natural infection during the era before the federal measles-elimination program and the early implementation of the measles-vaccination program. The measles epidemic during 1989 -1991 produced Ͼ55,000 cases, with a 4 -7-fold-higher incidence in nonwhite children [24] . Because participants were not asked whether they had ever had measles, the present study's data cannot be used to assess the reason for this significantly higher seropositivity for measles in non-Hispanic blacks.
Routine vaccination for measles began in Mexico in 1973 [23] . In the present study, foreign-born Mexican Americans who were born after that year (i.e., 1977 or later) had lower seropositivity for measles antibody than did US-born Mexican Americans. This difference may be due to lower vaccination rates in the foreign-born population and reduced circulation of measles in Mexico, as a result of the initiation of the vaccination program.
In 1994, the Vaccines for Children Program, a national initiative that entitled uninsured or underinsured children to free vaccine, was launched [25] . This initiative, along with the change to the 2-dose measles-vaccination schedule [26] and the increasingly successful school immunization laws [27] , coincides with the consistently high levels of seroprevalence of measles antibody, in all race/ethnic groups, that were achieved during the mid 1990s.
The present study has several limitations. Previous studies comparing commercially available EIA assay versus the goldstandard plaque reduction-neutralization assay have demonstrated that EIA was less sensitive but is a reliable identifier of measles-seronegative individuals. [28, 29] . Also, the assay used in the present study was not directly comparable to the method used in NHANES III [7] , so the seroprevalences of measles antibody in the 2 surveys could not be directly compared. Participants in the present study were not asked whether they had ever had measles, and MCV vaccination status was not recorded; therefore, the relationship between changes in the seroprevalence of measles antibody and vaccinations programs is speculative. In addition, the data regarding a participant's socioeconomic status, used to predict current serostatus for measles in the present study, may not correctly reflect that participant's socioeconomic status at the likely time of vaccination.
Data from NHANES 1999 -2004 demonstrate that the seroprevalence of measles antibody in the United States was highand, in all population subgroups except the 1967-1976 birth cohort, adequate to ensure that the elimination of endemic measles can be maintained. These data are consistent with other epidemiologic and vaccination-coverage data. Nonetheless, measles remains endemic in most of the world; therefore, the risk of reintroduction of the virus into the United States is high [29] . Maintenance of high levels of vaccine-induced measles antibody, via consistent implementation of the recommendations of the Advisory Committee on Immunization Practices, can ensure that the elimination of measles in the United States is maintained.
